Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | F10 | P00742 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1802084 | 1.00 | KDM4E (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL29416612 | 1.00 | KDM4E (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL16661674 | 1.00 | KDM4E (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL120159 | 1.00 | KDM4E (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL12846200 | 1.00 | KDM4E (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL23979434 | 1.00 | KDM4E (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL1797280 | 0.94 | SMN1; SMN2 (0.33) | KDM4EHTTSMN1; SMN2F2F10 | |
| SCHEMBL28721787 | 0.93 | CA1 (0.32) | KDM4ECA1CA2HTTRAB9A | |
| SCHEMBL12846257 | 0.93 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL12846202 | 0.92 | PDK2 (0.34) | KDM4ECA1CA2HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4008329-B1 | ISOXAZOLINE COMPOUNDS FOR USE IN TREATING DEMODICOSIS | INTERVET INT BV (NL) | 2025-06-11 | — | — | EP | claimed |
| EP-2833867-B2 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | INTERVET INT BV (NL) | 2023-05-10 | — | — | EP | claimed |
| US-11285101-B2 | Soft chewable pharmaceutical products | INTERVET INC. (US) | 2022-03-29 | — | — | US | claimed |
| CN-107616168-B | Aqueous suspension pesticide composition | 日产化学工业株式会社 | 2021-12-03 | — | — | CN | claimed |
| CN-106659160-B | Insecticidal or fungicidal composition and method for controlling plant diseases and pests | 日产化学工业株式会社 | 2020-08-21 | — | — | CN | claimed |
| US-20190201332-A1 | Soft Chewable Pharmaceutical Products | INTERVET INC. (US) | 2019-07-04 | — | — | US | claimed |
| EP-3079474-B1 | ANTIPARASITIC USE OF ISOXAZOLINE COMPOUNDS | INTERVET INT BV (NL) | 2019-07-03 | — | — | EP | claimed |
| US-10321683-B2 | Insecticidal, miticidal, nematicidal, molluscicidal, microbicidal, or bactericidal composition and method for controlling pest | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-06-18 | — | — | US | claimed |
| US-20180271095-A1 | PESTICIDAL MIXTURE COMPRISING A PYRAZOLE COMPOUND, AN INSECTICIDE AND A FUNGICIDE | BASF SE (DE) | 2018-09-27 | — | — | US | claimed |
| EP-3255990-A2 | PESTICIDAL MIXTURE COMPRISING A PYRAZOLE COMPOUND, AN INSECTICIDE AND A FUNGICIDE | BASF SE (DE) | 2017-12-20 | — | — | EP | claimed |
| US-20120149570-A1 | Foamable Pesticide Compositions And Methods Of Application | BASF CORPORATION (US) | 2012-06-14 | — | — | US | claimed |
| EP-2424370-A2 | FOAMABLE PESTICIDE COMPOSITIONS | BASF Corporation (US) | 2012-03-07 | — | — | EP | claimed |
| EP-2424347-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | BASF Corporation (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2011147952-A1 | PESTICIDAL MIXTURES | BASF SE (DE) | 2011-12-01 | — | — | WO | claimed |
| WO-2011025789-A2 | FOAMABLE PESTICIDE COMPOSITIONS AND METHODS OF APPLICATION | BASF CORPORATION (US) | 2011-03-03 | — | — | WO | claimed |
| US-20100322892-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| US-20100323897-A1 | FOAMABLE PESTICIDE COMPOSITIONS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| US-20100322990-A1 | METHODS FOR CONTROLLING PESTS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| WO-2010129345-A2 | FOAMABLE PESTICIDE COMPOSITIONS | BASF CORPORATION (US) | 2010-11-11 | — | — | WO | claimed |
| WO-2010127019-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | BASF CORPORATION (US) | 2010-11-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149570-A1 | Foamable Pesticide Compositions And Methods Of Application | DDT, PLD1, ACHE | KDM4E 4540/4885CA1 929/4885CA2 1991/4885 |
| US-11285101-B2 | Soft chewable pharmaceutical products | PAM, TAS2R46, TAS2R16 | KDM4E 2334/4885CA1 1332/4885CA2 158/4885 |
| US-20100323897-A1 | FOAMABLE PESTICIDE COMPOSITIONS | DDT, PON1, ACHE | KDM4E 2927/4885CA1 2387/4885CA2 2507/4885 |
| US-20180271095-A1 | PESTICIDAL MIXTURE COMPRISING A PYRAZOLE COMPOUND, AN INSECTICIDE AND A FUNGICIDE | PIK3C3, PMM2, PIR | KDM4E 4135/4885CA1 2334/4885CA2 2861/4885 |
| US-20100322990-A1 | METHODS FOR CONTROLLING PESTS | DDT, ACHE, PON1 | KDM4E 1971/4885CA1 2289/4885CA2 2176/4885 |
| US-20100322892-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | DDT, ACHE, CHRM2 | KDM4E 3406/4885CA1 2802/4885CA2 2561/4885 |
| US-10321683-B2 | Insecticidal, miticidal, nematicidal, molluscicidal, microbicidal, or bactericidal composition and method for controlling pest | DDT, ACHE, DRD5 | KDM4E 240/4885CA1 3995/4885CA2 1977/4885 |
| US-20190201332-A1 | Soft Chewable Pharmaceutical Products | PAM, TAS2R46, TAS2R16 | KDM4E 2334/4885CA1 1332/4885CA2 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.